RTTNews | Sep 23, 2020 10:29AM EDT

10:29 Wednesday, September 23, 2020 (RTTNews.com) - MediciNova, Inc. (MNOV) shares are rising on Wednesday morning trade after the biopharma company announced the intranasal SARS CoV-2 vaccine prototype for COVID-19.

The company confirmed a high IgA antibody titer against S1 Ag in the nasal lavage fluid from mice given intranasal BC-PIV SARS-CoV-2 vaccine.

Currently, the shares are at $6.16, up 11.37 percent from its previous close of $5.54 on a volume of 11,322,469. The stock has traded in a range of $2.79 to $13.25 on average volume of 1,668,170.

Read the original article on RTTNews ( https://www.rttnews.com/3130929/stock-alert-medicinova-gains-11-on-positive-covid-19-vaccine-data.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2020 RTTNews.com All Rights Reserved